Grantham, Mayo, Van Otterloo & Co (GMO)
ASRT

Grantham, Mayo, Van Otterloo & Co (GMO)’s Assertio ASRT Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ASRT Stock Details ASRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-260
Closed -$20K – 688
2019
Q3 		$20K Buy
+260
New +$33.9K ﹤0.01% 718
2017
Q1 		– Sell
-4,275
Closed -$4.62M – 581
2016
Q4 		$4.62M Buy
4,275
+2,570
+151% +$3.27M 0.02% 244
2016
Q3 		$2.56M Buy
+1,705
New +$2.14M 0.01% 309

Other funds holding ASRT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ASRT Position: Q4 2019 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Assertio (ASRT) in Q4 2019, closing a stake of 260 shares — an estimated $20K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ASRT in Q3 2016 and held it in 3 quarters. The position peaked at $4.62M in Q4 2016. 111 funds tracked by Wall St. Rank hold ASRT as of Q4 2019.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Assertio position as of Q4 2019 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 260 Assertio shares in Q4 2019, an estimated $20K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Assertio in Q3 2016 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Assertio position peaked at $4.62M in Q4 2016.
  • 111 funds tracked by Wall St. Rank held Assertio as of Q4 2019.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2019, filed 13 Feb 2020.